Physician profile
Vincent Mandas
NPI 1114389152
$2,925.38
in general payments reported to CMS, 2019-2025
13 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,868 · 2021: $504 · 2023: $15.20 · 2024: $382 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,635.77 | 2019-2023 | Tenotac 2.0 |
| Cdc Medical LLC | $361.00 | 2019 | |
| Stryker Corporation | $230.15 | 2019-2024 | Allomatrix, Ortholoc 3di, Ortholoc 2 Lapifuse |
| Access Pro Medical, LLC | $140.75 | 2025 | Matriderm |
| Medtronic, INC. | $128.70 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Horizon Therapeutics Plc | $122.11 | 2019 | |
| Sanara Medtech INC. | $97.81 | 2024 | Celleraterx |
| Cardiovascular Systems INC. | $90.90 | 2019 | |
| Organogenesis INC. | $30.01 | 2024 | |
| Bioventus LLC | $29.83 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $28.22 | 2024 | Iovera, Zilretta, Exparel |
| Cosa Medical, LLC | $22.86 | 2024 | |
| Orthofix Medical, INC. | $7.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Mandas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.